These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20043080)

  • 1. Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids.
    Bai VU; Murthy S; Chinnakannu K; Muhletaler F; Tejwani S; Barrack ER; Kim SH; Menon M; Veer Reddy GP
    Int J Oncol; 2010 Feb; 36(2):443-50. PubMed ID: 20043080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement.
    Bidaux G; Roudbaraki M; Merle C; Crépin A; Delcourt P; Slomianny C; Thebault S; Bonnal JL; Benahmed M; Cabon F; Mauroy B; Prevarskaya N
    Endocr Relat Cancer; 2005 Jun; 12(2):367-82. PubMed ID: 15947109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?
    Zhang L; Barritt GJ
    Endocr Relat Cancer; 2006 Mar; 13(1):27-38. PubMed ID: 16601277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function.
    Bidaux G; Flourakis M; Thebault S; Zholos A; Beck B; Gkika D; Roudbaraki M; Bonnal JL; Mauroy B; Shuba Y; Skryma R; Prevarskaya N
    J Clin Invest; 2007 Jun; 117(6):1647-57. PubMed ID: 17510704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
    Patel K; Whelan PJ; Prescott S; Brownhill SC; Johnston CF; Selby PJ; Burchill SA
    Clin Cancer Res; 2004 Nov; 10(22):7511-9. PubMed ID: 15569981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
    Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
    Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
    Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer.
    Sidiropoulos M; Chang A; Jung K; Diamandis EP
    Br J Cancer; 2001 Aug; 85(3):393-7. PubMed ID: 11487271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
    Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
    Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
    Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H
    Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.
    Gross M; Top I; Laux I; Katz J; Curran J; Tindell C; Agus D
    Clin Cancer Res; 2007 Apr; 13(7):1979-86. PubMed ID: 17404077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
    Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
    Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
    Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
    Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?
    Daja MM; Aghmesheh M; Ow KT; Rohde PR; Barrow KD; Russell PJ
    Mol Urol; 2000; 4(4):421-7. PubMed ID: 11156711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
    Agoulnik IU; Vaid A; Nakka M; Alvarado M; Bingman WE; Erdem H; Frolov A; Smith CL; Ayala GE; Ittmann MM; Weigel NL
    Cancer Res; 2006 Nov; 66(21):10594-602. PubMed ID: 17079484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.